We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This collaboration, with Lilly’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy.
Collaboration for Impact with Our New Partnership with Lilly
At FPN, our commitment to improving the lives of those living with peripheral neuropathy is unwavering. From advocating for increased awareness to funding groundbreaking research, we strive to make meaningful progress in understanding and treating this complex condition. By joining forces with Lilly, we are bolstering our efforts to provide support and resources to individuals living with this condition and their families and caregivers.
Peripheral neuropathy impacts millions of people worldwide, causing symptoms such as numbness, tingling, and pain in the extremities. It can be debilitating, impacting daily activities, and diminishing quality of life. Lilly shares our dedication to enhancing patient care and improving health outcomes. Through their innovative research, cutting-edge technologies, and commitment to community engagement, they have demonstrated a profound understanding of the challenges faced by individuals with peripheral neuropathy. Together, we will leverage our collective expertise and resources to drive advancements in diagnosis, treatment, and ultimately, finding cures.Â
As we embark on this journey together, we extend our heartfelt gratitude to Lilly for their unwavering support and commitment to our shared mission. We are changing lives and shaping a brighter future for generations to come.
For more information about corporate partnerships like these, please reach out to Lindsay Colbert, Executive Director, at [email protected].